Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Naltrexone for Children With PDD
NCT00318162Phase 2Unknown
- Sponsor
- Hadassah Medical Organization
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone in pervasive developmental disorder (PDD), sponsored by Hadassah Medical Organization. Status: unknown.
02
Drugs
naltrexone
03
Conditions
pervasive developmental disorder (PDD)
Beyond the preview
Go deeper on NCT00318162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00318162.